Ostatní
Návod 
Envista Holdings Corp
NVST
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.3B
Obrat
3B
Zisk
0B
Aktiva
6B
Dluh
2B
ROE
0%
ROA
0%
PE
102
PS
2
Cena 1R
14-25
⌀ Cena
19.74
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
05-02-2026
Poslední dividenda
Profil
Společnost Envista Holdings Corporation se spolu se svými dceřinými společnostmi zabývá vývojem, prodejem a prodejem zubních produktů ve Spojených státech, Číně a na mezinárodní úrovni. Společnost působí ve dvou segmentech, Specialty Products & Technologies a Equipment & Consumables. Segment Specialty Products & Technologies společnosti poskytuje zubní implantační systémy, řízené chirurgické systémy, biomateriály a prefabrikovaná a na míru postavená protetika orálním chirurgům, prosthodontistům a periodontistům pod značkami Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera a Orascoptic; a držáky a dráty, trubice a pásky, archivy, čisté aligery, digitální ortodontické ošetření, zadržovače a další ortodontické laboratorní produkty pod značkami Damon, Insignia, AOA a značky Spark. Tento segment také nabízí softwarové balíčky, které zahrnují DTX Studio Implant pro plánování léčby zubních implantátů, TX Studio Lab pro plánování léčby protetiky a DTX Studio Clinic pro ukládání a přístup k různým klinickým obrazům pacientů. Segment zařízení a spotřebního materiálu společnosti poskytuje zubní zařízení a potřeby, včetně digitálních zobrazovacích systémů, čidel, softwaru a dalších vizualizačních/zvětšovacích systémů; endodontické systémy a související spotřební materiál; restorativní materiály, rotační zátěže, otiskové materiály, pojiva a cementy; a produkty pro prevenci infekcí. Tento segment nabízí své produkty pod Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo a CaviWipes zubním ordinacím, klinikám a nemocnicím. Společnost Envista Holdings Corporation byla založena v roce 2018 a sídlí v Brea v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Equipment & Services
Počet zaměstnanců
12300
Založení
2019-09-18
Podobné společnosti
$ 23.36
- $ 0.07
$ 11.02
- $ 0.16
$ 45.02
- $ 1.00
$ 16.40
+ $ 0.07
$ 30.45
- $ 0.18
$ 143.25
+ $ 3.09
$ 55.95
+ $ 1.24
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 2,719.5 | 2,719.5 | 2,510.6 | 2,566.5 | 2,569.1 | 2,508.9 | 2,282.0 | 2,751.6 | 2,844.5 | 2,810.9 | 2,785.4 | |
| Cost of Revenues | 1,225.1 | 1,223.2 | 1,119.0 | 1,116.0 | 1,094.3 | 1,082.4 | 1,123.9 | 1,238.5 | 1,242.7 | 1,189.7 | 1,184.3 | |
| Gross Profit | 1,494.4 | 1,496.3 | 1,391.6 | 1,450.5 | 1,474.8 | 1,426.5 | 1,158.1 | 1,513.1 | 1,601.8 | 1,621.2 | 1,601.1 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 750.6 | 669.9 | 682.1 | 616.9 | 652.9 | 601.0 | 633.1 | 623.6 | 645.6 | 631.3 | |
| Cost of Revenues | 337.5 | 294.8 | 311.9 | 280.9 | 279.6 | 283.6 | 303.2 | 265.6 | 309.7 | 268.0 | |
| Gross Profit | 413.1 | 375.1 | 370.2 | 336.0 | 373.3 | 317.4 | 329.9 | 358.0 | 335.9 | 363.3 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 93.8 | 100.1 | 100.5 | 100.8 | 154.7 | 172.0 | 172.4 | 142.8 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 1,056.9 | 1,055.5 | 1,019.8 | 1,024.0 | 1,080.9 | 1,131.4 | 1,062.2 | 1,055.5 | |
| Depreciation & Amortization | 124.4 | 116.0 | 123.1 | 162.6 | 165.2 | 154.3 | 162.2 | 168.1 | 130.0 | 121.4 | 127.2 | |
| Total Operating Expenses | 1,264.0 | 1,270.6 | 2,429.8 | 1,419.0 | 1,155.6 | 1,120.3 | 1,124.8 | 1,235.6 | 1,303.4 | 1,234.6 | 1,198.3 | |
| Operating Income | 230.4 | 225.7 | -1,038.2 | 31.5 | 319.2 | 306.2 | 33.3 | 110.9 | 298.4 | 386.6 | 402.8 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.2 | 22.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 260.2 | 257.7 | ||
| Depreciation & Amortization | 29.1 | 29.2 | 29.8 | 36.3 | 27.8 | 29.2 | 34.0 | 32.1 | 40.0 | 39.6 | ||
| Total Operating Expenses | 337.3 | 310.3 | 319.4 | 297.0 | 327.2 | 296.5 | 1,483.2 | 309.9 | 280.4 | 280.0 | ||
| Operating Income | 75.8 | 64.8 | 50.8 | 39.0 | 46.1 | 20.9 | -1,153.3 | 48.1 | -202.8 | 83.3 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 36.6 | 36.6 | 46.4 | 63.4 | 38.4 | 54.1 | 62.5 | 3.5 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -53.2 | -48.5 | -46.5 | -86.4 | -35.3 | -51.7 | -63.4 | 164.6 | 2.7 | 0.1 | -1.1 | |
| IBT | 177.2 | 177.2 | -1,084.7 | -54.9 | 283.9 | 254.5 | -30.1 | 275.5 | 301.1 | 386.7 | 401.7 | |
| Income Tax Expense | 130.2 | 130.2 | 33.9 | 45.3 | 45.9 | -9.0 | -63.4 | 57.9 | 70.4 | 85.6 | 129.7 | |
| Net Income | 47.0 | 47.0 | -1,118.6 | -100.2 | 243.1 | 263.5 | 33.3 | 217.6 | 230.7 | 301.1 | 272.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.4 | ||
| Interest Expense | 10.3 | 9.0 | 8.0 | 9.3 | 9.9 | 11.9 | 11.7 | 12.9 | 13.9 | 15.4 | ||
| Other Expense | -18.2 | -14.9 | -10.1 | -10.0 | -9.6 | -11.3 | -12.8 | -12.8 | -12.2 | -47.5 | ||
| IBT | 57.6 | 49.9 | 40.7 | 29.0 | 36.5 | 9.6 | -1,166.1 | 35.3 | -215.0 | 35.8 | ||
| Income Tax Expense | 24.7 | 80.2 | 14.3 | 11.0 | 35.3 | 1.4 | -14.5 | 11.7 | 2.4 | 14.3 | ||
| Net Income | 32.9 | -30.3 | 26.4 | 18.0 | 1.2 | 8.2 | -1,151.6 | 23.6 | -217.4 | 21.5 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.60 | $1.51 | $1.63 | $0.21 | $1.60 | $1.49 | $1.95 | $1.76 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.60 | $1.37 | $1.48 | $0.20 | $1.60 | $1.49 | $1.95 | $1.76 | |
| Shares Outstanding | 164.4 | 168.0 | 172.2 | 166.9 | 161.2 | 161.2 | 159.6 | 136.2 | 154.6 | 154.6 | 154.6 | |
| Diluted Shares Outstanding | 166.0 | 169.2 | 172.2 | 166.9 | 177.6 | 177.6 | 164.1 | 136.4 | 154.6 | 154.6 | 154.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.27 | $0.13 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-1.27 | $0.12 | ||
| Shares Outstanding | 164.4 | 169.2 | 169.0 | 172.4 | 172.5 | 172.2 | 172.1 | 171.9 | 171.7 | 168.2 | ||
| Diluted Shares Outstanding | 166.0 | 170.3 | 169.9 | 173.6 | 172.2 | 172.9 | 172.1 | 173.4 | 171.7 | 175.2 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,036.2 | 1,069.1 | 940.0 | 606.9 | 1,073.6 | 888.9 | 211.2 | 0.0 | 0.0 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 1,036.2 | 1,069.1 | 940.0 | 606.9 | 1,073.6 | 888.9 | 211.2 | 0.0 | 0.0 | |
| Accounts Receivable | 380.6 | 363.0 | 407.5 | 393.5 | 331.9 | 361.0 | 443.6 | 459.8 | 463.1 | |
| Inventory | 263.8 | 241.0 | 258.8 | 300.8 | 263.8 | 266.9 | 277.9 | 278.7 | 275.7 | |
| Other Current Assets | 141.3 | 115.2 | 137.4 | 123.4 | 154.3 | 73.7 | 69.2 | 48.3 | 55.7 | |
| Total Current Assets | 1,821.9 | 1,788.3 | 1,743.7 | 1,424.6 | 1,835.8 | 1,590.5 | 1,001.9 | 786.8 | 794.5 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 1,133.9 | 1,110.6 | 1,077.3 | 1,069.1 | 991.3 | 1,036.2 | 948.5 | 940.0 | 824.2 | 651.7 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 1,133.9 | 1,110.6 | 1,077.3 | 1,069.1 | 991.3 | 1,036.2 | 948.5 | 940.0 | 824.2 | 651.7 | |
| Accounts Receivable | 405.9 | 422.8 | 393.1 | 363.0 | 392.1 | 380.6 | 413.0 | 407.5 | 417.1 | 415.2 | |
| Inventory | 290.8 | 281.9 | 261.3 | 241.0 | 265.6 | 263.8 | 267.4 | 258.8 | 278.8 | 297.0 | |
| Other Current Assets | 117.7 | 119.6 | 118.0 | 115.2 | 148.0 | 141.3 | 143.0 | 137.4 | 120.6 | 125.0 | |
| Total Current Assets | 1,948.3 | 1,934.9 | 1,849.7 | 1,788.3 | 1,797.0 | 1,821.9 | 1,771.9 | 1,743.7 | 1,640.7 | 1,488.9 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 415.8 | 419.8 | 434.7 | 425.4 | 392.2 | 468.3 | 490.4 | 261.6 | 231.2 | |
| Goodwill | 2,283.7 | 2,261.9 | 3,292.2 | 3,496.6 | 3,132.0 | 3,430.7 | 3,306.0 | 3,325.5 | 3,370.0 | |
| Intangible Assets | 698.1 | 649.9 | 954.0 | 1,086.7 | 1,046.4 | 1,259.2 | 1,285.6 | 1,390.3 | 1,515.9 | |
| Long-Term Investments | 0.0 | 26.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 218.6 | 204.2 | 180.5 | 153.7 | 167.8 | 127.3 | 74.4 | 77.4 | 81.2 | |
| Total Long-Term Assets | 3,616.2 | 3,562.2 | 4,861.4 | 5,162.4 | 4,738.4 | 5,285.5 | 5,156.4 | 5,054.8 | 5,198.3 | |
| Total Assets | 5,438.1 | 5,350.5 | 6,605.1 | 6,587.0 | 6,574.2 | 6,876.0 | 6,158.3 | 5,841.6 | 5,992.8 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 436.4 | 428.9 | 418.4 | 419.8 | 433.2 | 415.8 | 431.5 | 434.7 | 430.6 | 429.7 | |
| Goodwill | 2,362.7 | 2,369.6 | 2,303.4 | 2,261.9 | 2,333.8 | 2,283.7 | 3,259.8 | 3,292.2 | 3,458.2 | 3,493.8 | |
| Intangible Assets | 645.8 | 666.1 | 650.2 | 649.9 | 696.1 | 698.1 | 918.7 | 954.0 | 1,001.4 | 1,043.1 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 26.4 | 27.6 | 0.0 | 0.0 | -185.7 | 0.0 | 0.0 | |
| Other Long-Term Assets | 249.3 | 264.9 | 244.7 | 204.2 | 223.0 | 218.6 | 174.4 | 180.5 | 152.9 | 151.7 | |
| Total Long-Term Assets | 3,694.2 | 3,729.5 | 3,616.7 | 3,562.2 | 3,713.7 | 3,616.2 | 4,784.4 | 4,861.4 | 5,043.1 | 5,118.3 | |
| Total Assets | 5,642.5 | 5,664.4 | 5,466.4 | 5,350.5 | 5,510.7 | 5,438.1 | 6,556.3 | 6,605.1 | 6,683.8 | 6,607.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 172.4 | 174.6 | 179.5 | 228.3 | 185.8 | 235.1 | 208.0 | 217.4 | 222.4 | |
| Short-Term Debt | 150.2 | 150.5 | 175.9 | 537.0 | 456.1 | 919.3 | 30.6 | 243.1 | 216.7 | |
| Other Current Liabilities | 386.0 | 348.8 | 279.1 | 392.5 | 505.8 | 481.7 | 418.0 | 122.1 | 137.0 | |
| Current Liabilities | 821.4 | 878.7 | 780.8 | 1,236.7 | 1,207.8 | 1,684.7 | 709.2 | 641.0 | 628.2 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 156.0 | 171.8 | 163.5 | 174.6 | 172.1 | 172.4 | 174.7 | 179.5 | 168.6 | 176.8 | |
| Short-Term Debt | 39.2 | 36.1 | 151.0 | 150.5 | 152.0 | 150.2 | 148.0 | 175.9 | 144.5 | 568.5 | |
| Other Current Liabilities | 626.5 | 331.8 | 322.7 | 348.8 | 341.6 | 309.9 | 288.0 | 279.1 | 306.1 | 265.1 | |
| Current Liabilities | 821.7 | 793.9 | 873.3 | 878.7 | 865.5 | 821.4 | 781.3 | 780.8 | 746.8 | 1,150.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,388.7 | 1,397.2 | 1,508.0 | 992.1 | 1,003.8 | 1,061.5 | 1,507.0 | 0.0 | 0.0 | |
| Capital Leases | 103.8 | 153.4 | 140.2 | 148.4 | 144.1 | 186.3 | 212.7 | 0.0 | 0.0 | |
| Def. Tax Liability | 103.8 | 0.0 | 0.0 | 0.0 | -5.1 | -4.8 | 381.4 | 0.0 | 0.0 | |
| Total Liabilities | 2,461.4 | 2,415.7 | 2,431.2 | 2,380.1 | 2,516.2 | 3,155.0 | 2,615.5 | 1,015.2 | 998.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1,562.9 | 1,560.1 | 1,409.5 | 1,397.2 | 1,423.0 | 1,492.5 | 1,498.0 | 1,508.0 | 1,493.3 | 992.4 | |
| Capital Leases | 156.7 | 151.1 | 148.5 | 153.4 | 153.6 | 138.3 | 140.0 | 140.2 | 141.7 | 145.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 126.2 | 133.4 | 133.4 | |
| Total Liabilities | 2,554.3 | 2,525.4 | 2,430.3 | 2,415.7 | 2,438.2 | 2,461.4 | 2,416.0 | 2,431.2 | 2,390.6 | 2,296.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 0.0 | 0.0 | |
| Retained Earnings | -496.8 | -487.4 | 631.2 | 731.4 | 466.9 | 126.4 | 93.1 | 0.0 | 0.0 | |
| Comprehensive Income | -301.6 | -371.1 | -217.2 | -225.1 | -143.5 | -91.8 | -144.2 | -78.2 | 0.6 | |
| Total Common Equity | 2,976.7 | 2,934.8 | 4,173.9 | 4,206.9 | 4,057.6 | 3,720.6 | 3,540.2 | 4,823.1 | 4,990.5 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.8 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | |
| Retained Earnings | -473.3 | -443.0 | -469.4 | -487.4 | -488.6 | -496.8 | 654.8 | 631.2 | 848.6 | 827.1 | |
| Comprehensive Income | -113.1 | -123.5 | -273.1 | -371.1 | -223.6 | -301.6 | -283.6 | -217.2 | -306.8 | -236.9 | |
| Total Common Equity | 3,088.2 | 3,139.0 | 3,036.1 | 2,934.8 | 3,072.5 | 2,976.7 | 4,140.3 | 4,173.9 | 4,293.2 | 4,311.0 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 1,642.7 | 1,547.7 | 1,653.6 | 1,529.1 | 1,459.9 | 1,980.8 | 1,537.6 | 0.0 | 0.0 | |
| Book Value | 2,976.7 | 2,934.8 | 4,173.9 | 4,206.9 | 4,058.0 | 3,721.0 | 3,542.8 | 4,826.4 | 4,994.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 3,088.2 | 3,139.0 | 3,036.1 | 2,934.8 | 3,072.5 | 2,976.7 | 4,140.3 | 4,173.9 | 4,293.2 | 4,311.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -1,323.9 | 47.0 | -1,118.6 | -100.2 | 243.1 | 340.5 | 33.3 | 217.6 | 230.7 | 301.1 | 272.0 | |
| Depreciation & Amortization | 153.0 | 116.0 | 154.5 | 162.6 | 162.1 | 151.9 | 163.1 | 168.1 | 130.0 | 121.4 | 127.2 | |
| Stock-Based Compensation | 26.8 | 0.0 | 35.3 | 30.7 | 30.5 | 28.2 | 22.6 | 18.4 | 13.3 | 12.3 | 10.5 | |
| Change Working Capital | 33.7 | 8.9 | 97.4 | -108.4 | -271.7 | -173.4 | -15.2 | -6.6 | 25.7 | -82.5 | -3.6 | |
| Change In Accounts Receivable | 12.1 | -48.5 | 10.0 | -17.0 | -71.0 | -43.2 | 71.9 | 12.8 | -3.8 | -18.9 | -27.3 | |
| Change In Accounts Payable | -4.2 | 7.5 | -1.2 | -46.3 | 44.5 | -20.3 | 21.6 | -7.9 | -3.8 | -0.5 | 15.3 | |
| Change In Inventories | 28.0 | -29.1 | 3.6 | 35.1 | -39.9 | -66.0 | 11.9 | -1.5 | -8.9 | -30.5 | -8.9 | |
| Other Non-cash Items | 1,692.6 | 92.4 | 1,196.9 | 328.0 | 47.7 | 34.1 | 24.5 | 8.9 | 0.4 | 6.8 | 10.9 | |
| Cash from Operations | 330.9 | 0.0 | 0.0 | 275.7 | 182.7 | 391.4 | 283.9 | 397.5 | 400.1 | 359.1 | 417.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 32.9 | -30.3 | 26.4 | 18.0 | 1.2 | 8.2 | -1,151.6 | 23.6 | -217.4 | 21.5 | |
| Depreciation & Amortization | 58.3 | 37.8 | -16.4 | 36.3 | 27.8 | 37.3 | 34.0 | 33.3 | 40.0 | 39.6 | |
| Stock-Based Compensation | -27.2 | 10.4 | 9.7 | 7.1 | 0.0 | 9.8 | 0.0 | 11.0 | 4.5 | 6.0 | |
| Change Working Capital | 29.3 | 32.3 | 11.6 | -64.3 | 62.3 | 13.1 | 62.0 | -37.3 | 14.7 | -3.0 | |
| Change In Accounts Receivable | -24.9 | 13.6 | -15.9 | -21.3 | 10.9 | -6.0 | 21.4 | -16.3 | 16.0 | -9.0 | |
| Change In Accounts Payable | 33.4 | -15.9 | 5.1 | -15.1 | 6.3 | -2.5 | -2.3 | 0.0 | 6.9 | -6.1 | |
| Change In Inventories | 5.5 | -11.1 | -13.4 | -10.1 | 15.2 | -0.6 | 1.2 | -12.2 | 25.7 | 13.3 | |
| Other Non-cash Items | 28.7 | 2.2 | 58.3 | 3.2 | 23.3 | 3.0 | 1,194.8 | 9.7 | 293.1 | 29.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 102.0 | 95.5 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -44.4 | -45.3 | -33.8 | -58.2 | -75.7 | -54.7 | -47.7 | -77.8 | -72.2 | -48.9 | -49.1 | |
| Acquisitions | -10.7 | 0.0 | 0.0 | 0.0 | -622.3 | 280.6 | -40.7 | 0.0 | 0.0 | 0.0 | -5.0 | |
| Investments | 16.8 | -9.9 | -32.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.9 | 10.4 | 9.7 | 10.7 | 56.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -16.8 | 0.0 | 0.0 | -14.9 | -15.3 | 7.0 | 19.3 | -0.6 | -3.3 | -6.0 | -5.3 | |
| Cash from Investing | -54.2 | 0.0 | 0.0 | -62.4 | -657.3 | 232.9 | -69.1 | -78.4 | -75.5 | -54.9 | -59.4 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -16.3 | -10.8 | -12.3 | -5.9 | -8.6 | -7.4 | -6.8 | -11.0 | -8.2 | -18.4 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | -10.7 | 0.0 | |
| Investments | -0.3 | -8.6 | -0.3 | -0.7 | -0.2 | -32.6 | 0.0 | 0.0 | 16.8 | 0.0 | |
| Sales of Investment | 0.5 | 9.0 | 0.2 | 0.7 | 0.5 | 8.8 | 0.4 | 0.0 | 0.5 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.0 | -6.6 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -12.6 | -25.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -1,380.0 | 0.0 | 0.0 | 133.7 | -124.5 | -475.7 | -250.0 | -0.3 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 1,490.3 | 1,547.7 | -105.9 | 258.2 | 193.7 | -45.2 | 693.2 | 1,537.9 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 7.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 643.4 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -4.9 | -166.6 | 0.0 | -7.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 1,489.8 | 0.0 | 0.0 | -6.9 | 137.0 | 10.1 | 742.5 | -750.8 | -324.6 | -304.2 | -357.6 | |
| Cash from Financing | 115.5 | 0.0 | 0.0 | 118.9 | 12.5 | -465.6 | 492.5 | -107.7 | -324.6 | -304.2 | -357.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 1,602.1 | 5.9 | 35.7 | 12.8 | -27.3 | -67.7 | -3.3 | -7.6 | 15.8 | 105.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 | 0.0 | |
| Repurchase of Common Stock | -24.3 | -42.0 | -85.7 | -14.6 | 0.0 | 0.0 | 0.0 | -3.3 | -0.1 | -1.4 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 114.5 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | 114.5 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 384.5 | 142.6 | 129.1 | 333.1 | -466.7 | 184.7 | 677.7 | 211.2 | 0.0 | 0.0 | 0.0 | |
| Closing Cash Balance | 1,036.2 | 1,211.7 | 1,069.1 | 940.0 | 606.9 | 1,073.6 | 888.9 | 211.2 | 0.0 | 0.0 | 0.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 77.8 | 23.3 | 33.3 | 8.2 | 77.8 | -44.9 | 87.7 | 8.5 | 115.8 | 172.5 | |
| Closing Cash Balance | 1,211.7 | 1,133.9 | 1,110.6 | 1,077.3 | 1,069.1 | 991.3 | 1,036.2 | 948.5 | 940.0 | 824.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 286.5 | 230.4 | 302.7 | 217.5 | 107.0 | 336.7 | 236.2 | 319.7 | 327.9 | 310.2 | 367.9 | |
| Real Free Cash Flow | 259.7 | 230.4 | 267.4 | 186.8 | 76.5 | 308.5 | 213.6 | 301.3 | 314.6 | 297.9 | 357.4 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 91.7 | 67.9 | 76.4 | -5.6 | 123.8 | 63.3 | 86.3 | 29.3 | 93.8 | 77.1 | |
| Real Free Cash Flow | 118.9 | 57.5 | 66.7 | -12.7 | 123.8 | 53.5 | 86.3 | 18.3 | 89.3 | 71.1 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 101.6 | 43.1 | 42.6 |
| P/S | 1.8 | 2 | 2.3 |
| P/B | 1.5 | 1.4 | 9.4 |
| P/FCF | 20.7 | 27.3 | 20.3 |
| Market cap | $3.3 | $3.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 20.3 % | 0 % |
| Debt to Income | 3408.7 % | 1383.4 % | 0 % |
| Debt to Free cash flow | 695.4 % | 11.1 % | 0 % |
| Interest expense percentage | 15.9 % | 44.5 % | 0 % |
| Current ratio | 2.4 | 1.4 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 1.5 % | -2 % | 0 % |
| ROA | 0.8 % | -0.9 % | 0 % |
| CapEx to Revenue | 1.7 % | 2.2 % | 0 % |
| RaD to Revenue | 0 % | 4.3 % | 0 % |
| ROEM | 221,097.6 | 138787.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 55 % | 55.2 % | 0 % |
| Operating margin | 8.5 % | 7.5 % | 0 % |
| Net margin | 1.7 % | -0.7 % | 0 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 166.0 mil | 167.6 mil |
| Employee count | 12.3 tis | 12.3 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
